Skip to main content

Peer Review reports

From: Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study

Original Submission
10 May 2017 Submitted Original manuscript
22 May 2017 Reviewed Reviewer Report - Lawrence Mbuagbaw
25 Jun 2017 Reviewed Reviewer Report - Anna-Marie Jones
27 Jun 2017 Reviewed Reviewer Report - Iulia Bogdan
1 Sep 2017 Author responded Author comments - Gill Webster
Resubmission - Version 2
1 Sep 2017 Submitted Manuscript version 2
23 Oct 2017 Author responded Author comments - Gill Webster
Resubmission - Version 3
23 Oct 2017 Submitted Manuscript version 3
Publishing
27 Oct 2017 Editorially accepted
16 Nov 2017 Article published 10.1186/s40814-017-0201-4

You can find further information about peer review here.

Back to article page